mazdutide vs retatrutide Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta‐Analysis of Randomised Controlled Trials This data from Phase 3

Thiebaud et al., 2016, 2019)

The forward-looking statements contained in this press release are based on our current expectations and beliefs concerning future developments and their potential effects on us

Combining genetic predisposition data with routine biomarker assessment (fasting glucose, HbA1c, metabolic panels) allows your provider to design a personalized injection strategy that aligns with your unique physiology

The result is a different starting point than the traditional liposuction patient

TSA: Traveling with Diabetes Medications , Transportation Security Administration

Clinical studies We split this section between studies of GLP-1RAs in people with mood disorders and studies of mood symptoms in patients with other medical conditions taking GLP-1RAs (Tables 4 and 5, and Extended Data Tables 5 and 6)